First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs

This is Part 3 of First-Line Immunotherapy for Metastatic NSCLC: Special Populations and Unmet Needs, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. ...

lung cancer

/ First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs

Patient With PD-L1–Negative Metastatic NSCLC

This is Part 2 of First-Line Immunotherapy for Metastatic NSCLC: Special Populations and Unmet Needs, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. ...

lung cancer

/ First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs

Patient With Metastatic Squamous NSCLC

This is Part 1 of First-Line Immunotherapy for Metastatic NSCLC: Special Populations and Unmet Needs, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. ...

First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs

Patient With Metastatic NSCLC and Brain Metastasis

Patient With PD-L1–Negative Metastatic NSCLC

Patient With Metastatic Squamous NSCLC

Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma

Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders

MRI First Strategy May Be Safe for Prostate Cancer Detection

Addition of SBRT to Systemic Therapy May Improve Outcomes in Select Patients With Locally Advanced Hepatocellular Carcinoma

Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL